RedHill Biopharma Ltd.RDHLNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank7
Year-over-Year Change
Year-over-year SG&A expense growth
Percentile
P7
Near historical low
vs 5Y Ago
-1x
Contraction
Streak
1 yr
Consecutive growthDecelerating
| Period | Value |
|---|---|
| 2024 | -49.90% |
| 2023 | -51.62% |
| 2022 | -27.23% |
| 2021 | 17.85% |
| 2020 | 150.42% |
| 2019 | 49.13% |
| 2018 | -0.23% |
| 2017 | 270.89% |
| 2016 | 30.70% |
| 2015 | 3.07% |